Servicio de Urología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Departamento de Cirugía, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
Servicio de Urología, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Departamento de Cirugía, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
Actas Urol Esp (Engl Ed). 2024 Sep;48(7):497-511. doi: 10.1016/j.acuroe.2023.11.009. Epub 2024 Feb 14.
Patients undergoing radical cystectomy with urinary diversions (UD) are at increased risk of bone fractures compared to the general population. Although a loss of bone mineral density (BMD) has been described in patients with UD, we still do not know with certainty why these patients follow this tendency.
We performed a systematic review of the available literature to analyze the prevalence of osteoporosis and bone alterations in patients with ileal UD and the possible associated risk factors.
We systematically searched PubMed® and Cochrane Library for original articles published before December 2022 according to PRISMA guidelines.
A total of 394 publications were identified. We selected 12 studies that met the inclusion criteria with 496 patients included. Six of the twelve studies showed decreased BMD values. Prevalence of osteoporosis was specified in three articles, with values ranging from 0% to 36%. Risk factors such as age, sex, body mass index, metabolic acidosis and renal function appear to have an impact on bone tissue reduction, while type of UD, follow-up, 25-hydroxyvitamin D and parathormone had less evidence or contradictory data. The heterogeneity of the studies analyzed could led to interpretation bias.
UD are associated with multiple risk factors for osteoporosis and bone fractures. Identifying patients at highest risk and establishing diagnostic protocols in routine clinical practice are essential to reduce the risk of fractures and the resulting complications.
与普通人群相比,接受根治性膀胱切除术和尿路改道(UD)的患者骨折风险增加。尽管已有研究描述了接受 UD 的患者存在骨密度(BMD)丢失的情况,但我们仍不确定为什么这些患者会出现这种趋势。
我们对现有文献进行了系统回顾,以分析有 UD 的患者骨质疏松症和骨改变的患病率,以及可能存在的相关危险因素。
我们按照 PRISMA 指南系统地在 PubMed®和 Cochrane Library 中搜索了 2022 年 12 月之前发表的原始文章。
共确定了 394 篇出版物。我们选择了符合纳入标准的 12 项研究,其中包括 496 名患者。这 12 项研究中有 6 项显示 BMD 值降低。有 3 篇文章明确了骨质疏松症的患病率,范围从 0%到 36%。年龄、性别、体重指数、代谢性酸中毒和肾功能等危险因素似乎对骨组织减少有影响,而 UD 类型、随访、25-羟维生素 D 和甲状旁腺激素的影响则证据较少或数据相互矛盾。分析的研究存在异质性,可能导致解释偏倚。
UD 与多种骨质疏松症和骨折的危险因素相关。确定风险最高的患者并在常规临床实践中建立诊断方案对于降低骨折风险和由此产生的并发症至关重要。